# Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial Fibrillation

> **NCT01061931** · PHASE4 · TERMINATED · sponsor: **Charite University, Berlin, Germany** · enrollment: 108 (estimated)

## Conditions studied

- Symptomatic Paroxysmal Atrial Fibrillation

## Interventions

- **PROCEDURE:** Arctic Front® catheter vs. HD Mesh Ablator® catheter

## Key facts

- **NCT ID:** NCT01061931
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2010-11
- **Final completion:** 2011-11
- **Target enrollment:** 108 (ESTIMATED)
- **Why stopped:** reason
- **Last updated:** 2014-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01061931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01061931, "Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01061931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
